Lexaria Bioscience (LEXX) Inventory Average (2015 - 2023)

Lexaria Bioscience has disclosed Inventory Average across 9 years of filings, most recently posting $8762.0 for Q1 2023.

• Inventory Average for Q1 2023 came in at $8762.0, down 70.24% year-over-year; the trailing twelve-month figure through Feb 2023 was $8762.0 (down 70.24% YoY), and the FY2022 annual result was $34033.0, down 53.54% from the prior year.
• Inventory Average came in at $8762.0 for Q1 2023 at Lexaria Bioscience, down from $24177.0 in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $157835.5 in Q3 2019 to a low of $8762.0 in Q1 2023.
• The 5-year median for Inventory Average is $65607.5 (2021), against an average of $79624.1.
• Across the five-year window, Inventory Average surged 113.16% in 2019 and slumped 70.24% in 2023, its largest moves.
• Lexaria Bioscience's Inventory Average stood at $130476.0 in 2019, then slumped by 57.54% to $55402.0 in 2020, then plunged by 48.91% to $28307.0 in 2021, then retreated by 14.59% to $24177.0 in 2022, then tumbled by 63.76% to $8762.0 in 2023.
• The last three Inventory Average figures came in at $8762.0 (Q1 2023), $24177.0 (Q4 2022), and $39300.5 (Q3 2022), per Business Quant data.